Mentice AB (publ), a globally recognized leader in simulation solutions for image-guided interventional therapies, today announced a $642,000 order from a top 20 global Med Tech company, a long-standing and valued customer. This order highlights the increasing demand for simulation-based training solutions to support clinical education, enhance procedural proficiency, and improve patient safety in interventional cardiology.
‍

“We are proud to support our partner in advancing procedural training and patient care,” said Frans Venker, CEO of Mentice. “This order reaffirms the growing reliance on simulation-based training and the strong commitment from medical technology companies to advance procedural safety and innovation.”

This order further strengthens Mentice position as a trusted partner for global healthcare innovators. Through its advanced simulation solutions, Mentice remains dedicated to delivering evidence-based, clinically relevant solutions that support healthcare providers and MedTech companies in facilitating educational initiatives that drive progress in interventional therapies and optimize patient care."

The order will be recognized under Mentice Medical Device Industry division in the coming months of 2025, contributing to the company’s growth strategy and expanding its presence in the market for interventional cardiology training solutions.
 
Mentice definition of a Top 20 Medical Technology company can be found here: https://www.beckershospitalreview.com/innovation/100-largest-medtech-companies.html

‍

Discover Our Cardiovascular Simulation Solutions

Learn more about how Mentice’s advanced simulation platforms are transforming interventional cardiology. Explore our full suite of cardiovascular solutions designed to enhance procedural training, improve patient outcomes, and support your clinical and educational objectives.
Explore Cardiovascular Solutions: https://www.mentice.com/cardiovascular

‍

‍
For more information, please contact:
Frans Venker, CEO, Mentice
Email: frans.venker@mentice.com
Mobile +46 (0) 735 25 30 81

‍